Related Experiment Videos
Indium-111 antimyosin monoclonal antibody Fab imaging in patients with cardiomyopathy
M Ishibashi1, T Wada, S Morita
1Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan.
Insights
Antimyosin antibody imaging shows potential for detecting myocardial injury in cardiomyopathy patients. This technique may help identify heart muscle damage in conditions like hypertrophic non-obstructive cardiomyopathy and dilated cardiomyopathy.
Area of Science:
- Cardiology
- Immunology
- Nuclear Medicine
Background:
- Cardiomyopathy encompasses various heart muscle diseases.
- Accurate diagnosis of myocardial injury is crucial for patient management.
Purpose of the Study:
- To evaluate the utility of indium-111 labeled antimyosin antibody imaging in patients with cardiomyopathy.
- To assess the ability of this imaging technique to detect myocardial injury or necrosis.
Main Methods:
- Six patients with cardiomyopathy underwent imaging after intravenous injection of indium-111 labeled antimyosin antibody.
- Patients included those with hypertrophic non-obstructive cardiomyopathy (HNCM), dilated cardiomyopathy (DCM), and specific heart muscle disease.
Main Results:
- One of two HNCM patients and one of two DCM patients showed a positive antimyosin scan, indicating myocardial injury.
- Two patients with specific heart muscle disease had persistent blood pool activity, hindering image interpretation.
Conclusions:
- Antimyosin antibody imaging may offer evidence of myocardial injury or necrosis in select cardiomyopathy cases.
- Further research is needed to optimize imaging protocols for specific heart muscle diseases.
Abstract:
Six patients with cardiomyopathy were imaged following intravenous injection of an indium-111 labeled monoclonal antibody directed against the heavy chain of cardiac myosin. Two patients had hypertrophic non-obstructive cardiomyopathy (HNCM), two patients had dilated cardiomyopathy (DCM), and two patients had specific heart muscle disease. One of 2 patients with HNCM and one of 2 patients with DCM had a positive antimyosin scan. The 2 patients with specific heart muscle disease manifested persistent blood pool activity of the antibody, thereby precluding interpretation of the images. The present report demonstrates that antimyosin antibody imaging may provide evidence of myocardial injury, or necrosis in some patients with cardiomyopathy.